{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T17:23:42Z","timestamp":1790875422299,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T00:00:00Z","timestamp":1754265600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T00:00:00Z","timestamp":1754265600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100016422","name":"Champ Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016422","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR001878"],"award-info":[{"award-number":["UL1TR001878"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The SLSMDS Research Network is a collaborative network comprising patient advocates, researchers, clinicians, and affected families seeking to improve outcomes for individuals with single large-scale mitochondrial DNA deletion syndromes (SLSMDS). Building off of jointly developed research infrastructures, including a patient registry and natural history study, advocates and clinicians cohosted the SLSMDS Family and Scientific Conference, enabling the collection of patient data from an ultra-rare and geographically dispersed patient population. Here we describe the data collection procedures for single-time point laboratory assessments and patient reported outcomes for a subset of individuals with SLSMDS.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Utilizing a reproducible model of rare disease data collection, we expand our understanding of the common psychiatric manifestations, describe variability in terms of self-care and quality of life, and emphasize potential biomarkers for individuals with SLSMDS.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Our study describes how efficient patient-researcher partnerships can develop and sustain novel mechanisms to collect rare disease data, improve our understanding of the natural history of these disorders, and support development of future treatments.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13023-025-03632-4","type":"journal-article","created":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T17:58:30Z","timestamp":1754330310000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Single large-scale mitochondrial DNA deletion syndromes: scientific and family conference optimizes the collection of rare disease research outcomes"],"prefix":"10.1186","volume":"20","author":[{"given":"Laura E.","family":"MacMullen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marissa","family":"Weis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"George-Sankoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katelynn D.","family":"Stanley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariya","family":"Redko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Poblete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy C.","family":"Goldstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca D.","family":"Ganetzky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,4]]},"reference":[{"key":"3632_CR1","volume-title":"Adam MP","author":"A Goldstein","year":"1993","unstructured":"Goldstein A, Falk MJ. Mitochondrial DNA deletion syndromes. In: Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, editors. Adam MP. Seattle (WA): GeneReviews; 1993."},{"issue":"3","key":"3632_CR2","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s10545-014-9778-4","volume":"38","author":"A Broomfield","year":"2015","unstructured":"Broomfield A, Sweeney MG, Woodward CE, et al. Paediatric single mitochondrial DNA deletion disorders: an overlapping spectrum of disease. J Inherit Metab Dis. 2015;38(3):445\u201357. https:\/\/doi.org\/10.1007\/s10545-014-9778-4.","journal-title":"J Inherit Metab Dis"},{"issue":"12","key":"3632_CR3","doi-asserted-by":"publisher","first-page":"e039473","DOI":"10.1136\/bmjopen-2020-039473","volume":"10","author":"A Roennow","year":"2020","unstructured":"Roennow A, Sauve M, Welling J, et al. Collaboration between patient organisations and a clinical research sponsor in a rare disease condition: learnings from a community advisory board and best practice for future collaborations. BMJ Open. 2020;10(12):e039473. https:\/\/doi.org\/10.1136\/bmjopen-2020-039473.","journal-title":"BMJ Open"},{"issue":"1","key":"3632_CR4","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s13023-022-02357-y","volume":"17","author":"G Velvin","year":"2022","unstructured":"Velvin G, Hartman T, Bathen T. Patient involvement in rare diseases research: a scoping review of the literature and mixed method evaluation of Norwegian researchers\u2019 experiences and perceptions. Orphanet J Rare Dis. 2022;17(1):212. https:\/\/doi.org\/10.1186\/s13023-022-02357-y.","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"3632_CR5","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.ymgme.2021.11.004","volume":"134","author":"E Reynolds","year":"2021","unstructured":"Reynolds E, Byrne M, Ganetzky R, et al. Pediatric single large-scale mtDNA deletion syndromes: the power of patient reported outcomes. Mol Genet Metab. 2021;134(4):301\u20138. https:\/\/doi.org\/10.1016\/j.ymgme.2021.11.004.","journal-title":"Mol Genet Metab"},{"key":"3632_CR6","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/1750-1172-9-81","volume":"9","author":"L Viviani","year":"2014","unstructured":"Viviani L, Zolin A, Mehta A, et al. The European cystic fibrosis society patient registry: valuable lessons learned on how to sustain a disease registry. Orphanet J Rare Dis. 2014;9:81. https:\/\/doi.org\/10.1186\/1750-1172-9-81.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"3632_CR7","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s13023-016-0537-5","volume":"11","author":"L Woodward","year":"2016","unstructured":"Woodward L, Johnson S, Walle JV, et al. An innovative and collaborative partnership between patients with rare disease and industry-supported registries: the global aHUS registry. Orphanet J Rare Dis. 2016;11(1):154. https:\/\/doi.org\/10.1186\/s13023-016-0537-5.","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"3632_CR8","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1002\/jmd2.12385","volume":"64","author":"M Chappell","year":"2023","unstructured":"Chappell M, Parikh S, Reynolds E. Understanding the impact of pediatric single large-scale mtDNA deletion syndromes on caregivers: Burdens and challenges. JIMD Rep. 2023;64(5):375\u201386. https:\/\/doi.org\/10.1002\/jmd2.12385.","journal-title":"JIMD Rep"},{"key":"3632_CR9","unstructured":"Newly diagnosed with Pearson Syndrome The Champ Foundation. https:\/\/thechampfoundation.org\/newly-diagnosed.html. Accessed"},{"issue":"1","key":"3632_CR10","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s13023-020-01389-6","volume":"15","author":"K Goodspeed","year":"2020","unstructured":"Goodspeed K, Bliss G, Linnehan D. Bringing everyone to the table\u2014findings from the 2018 Phelan-McDermid syndrome foundation international conference. Orphanet J Rare Dis. 2020;15(1):152. https:\/\/doi.org\/10.1186\/s13023-020-01389-6.","journal-title":"Orphanet J Rare Dis"},{"issue":"10","key":"3632_CR11","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1038\/s41591-020-1098-7","volume":"26","author":"C Ainsworth","year":"2020","unstructured":"Ainsworth C. Rare diseases band together toward change in research. Nat Med. 2020;26(10):1496\u20139. https:\/\/doi.org\/10.1038\/s41591-020-1098-7.","journal-title":"Nat Med"},{"issue":"1","key":"3632_CR12","doi-asserted-by":"publisher","first-page":"151696","DOI":"10.1016\/j.semperi.2022.151696","volume":"47","author":"J Canvasser","year":"2023","unstructured":"Canvasser J, Patel RM, Pryor E, et al. Long-term outcomes and life-impacts of necrotizing enterocolitis: a survey of survivors and parents. Semin Perinatol. 2023;47(1):151696. https:\/\/doi.org\/10.1016\/j.semperi.2022.151696.","journal-title":"Semin Perinatol"},{"key":"3632_CR13","doi-asserted-by":"publisher","unstructured":"U.S. Department of Health and Human Services Food and Drug Administration. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims. Services USDoHaH. 2006\/10\/13 ed. https:\/\/www.fda.gov\/media\/77832\/download2009. p. 79. https:\/\/doi.org\/10.1186\/1477-7525-4-79","DOI":"10.1186\/1477-7525-4-79"},{"issue":"2","key":"3632_CR14","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1037\/sah0000018","volume":"1","author":"KR Bogart","year":"2016","unstructured":"Bogart KR, Hemmesch AR. Benefits of support conferences for parents of and people with Moebius syndrome. Stigma Health. 2016;1(2):109\u201321. https:\/\/doi.org\/10.1037\/sah0000018.","journal-title":"Stigma Health"},{"issue":"1","key":"3632_CR15","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s40271-014-0085-9","volume":"8","author":"M Doyle","year":"2015","unstructured":"Doyle M. Peer support and mentorship in a US rare disease community: findings from the cystinosis in emerging adulthood study. Patient. 2015;8(1):65\u201373. https:\/\/doi.org\/10.1007\/s40271-014-0085-9.","journal-title":"Patient"},{"key":"3632_CR16","doi-asserted-by":"publisher","first-page":"886552","DOI":"10.3389\/fendo.2022.886552","volume":"13","author":"J Raskin","year":"2022","unstructured":"Raskin J, Pasquini TLS, Bose S, et al. Congenital hyperinsulinism international: a community focused on improving the lives of people living with congenital hyperinsulinism. Front Endocrinol (Lausanne). 2022;13:886552. https:\/\/doi.org\/10.3389\/fendo.2022.886552.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"3632_CR17","unstructured":"The New York Times. https:\/\/www.nytimes.com\/2015\/09\/07\/us\/flicker-of-hope-for-children-with-rare-and-devastating-disease.html. Accessed 19 Jun 2024"},{"issue":"12","key":"3632_CR18","doi-asserted-by":"publisher","first-page":"e017599","DOI":"10.1136\/bmjopen-2017-017599","volume":"7","author":"CCG Silier","year":"2017","unstructured":"Silier CCG, Greschik J, Gesell S, et al. Chronic non-bacterial osteitis from the patient perspective: a health services research through data collected from patient conferences. BMJ Open. 2017;7(12):e017599. https:\/\/doi.org\/10.1136\/bmjopen-2017-017599.","journal-title":"BMJ Open"},{"key":"3632_CR19","doi-asserted-by":"publisher","first-page":"61","DOI":"10.4236\/ojgen.2013.31007","volume":"3","author":"C Strom","year":"2013","unstructured":"Strom C, Park N, Morgan C, et al. Tay-Sachs carrier screening in the genomics age: gene sequencing versus enzyme analysis in non-Jewish individuals. Open J Genet. 2013;3:61\u20136. https:\/\/doi.org\/10.4236\/ojgen.2013.31007.","journal-title":"Open J Genet"},{"issue":"2","key":"3632_CR20","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.cct.2013.04.004","volume":"35","author":"EA de Blieck","year":"2013","unstructured":"de Blieck EA, Augustine EF, Marshall FJ, et al. Methodology of clinical research in rare diseases: development of a research program in juvenile neuronal ceroid lipofuscinosis (JNCL) via creation of a patient registry and collaboration with patient advocates. Contemp Clin Trials. 2013;35(2):48\u201354. https:\/\/doi.org\/10.1016\/j.cct.2013.04.004.","journal-title":"Contemp Clin Trials"},{"key":"3632_CR21","first-page":"1","volume":"160","author":"CD Fryar","year":"2021","unstructured":"Fryar CD, Kruszon-Moran D, Gu Q, et al. Mean body weight, height, waist circumference, and body mass index among children and adolescents: United States, 1999\u20132018. Natl Health Stat Report. 2021;160:1\u201324.","journal-title":"Natl Health Stat Report"},{"issue":"6","key":"3632_CR22","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1007\/s11136-010-9649-x","volume":"19","author":"U Ravens-Sieberer","year":"2010","unstructured":"Ravens-Sieberer U, Wille N, Badia X, et al. Feasibility, reliability, and validity of the EQ-5D-Y: results from a multinational study. Qual Life Res. 2010;19(6):887\u201397. https:\/\/doi.org\/10.1007\/s11136-010-9649-x.","journal-title":"Qual Life Res"},{"issue":"7","key":"3632_CR23","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1002\/1097-0142(19871001)60:7<1651::aid-cncr2820600738>3.0.co;2-j","volume":"60","author":"SB Lansky","year":"1987","unstructured":"Lansky SB, List MA, Lansky LL, et al. The measurement of performance in childhood cancer patients. Cancer. 1987;60(7):1651\u20136. https:\/\/doi.org\/10.1002\/1097-0142(19871001)60:7%3c1651::aid-cncr2820600738%3e3.0.co;2-j.","journal-title":"Cancer"},{"issue":"1","key":"3632_CR24","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1177\/1545968311412054","volume":"26","author":"JS Lai","year":"2012","unstructured":"Lai JS, Nowinski C, Victorson D, et al. Quality-of-life measures in children with neurological conditions: pediatric Neuro-QOL. Neurorehabil Neural Repair. 2012;26(1):36\u201347. https:\/\/doi.org\/10.1177\/1545968311412054.","journal-title":"Neurorehabil Neural Repair"},{"issue":"1","key":"3632_CR25","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1177\/0829573514542924","volume":"30","author":"RL Fraccaro","year":"2015","unstructured":"Fraccaro RL, Stelnicki AM, Nordstokke DW. Test Review: Multidimensional Anxiety Scale for Children by J. S. March. Can J Sch Psychol. 2015;30(1):70\u20137.","journal-title":"Can J Sch Psychol"},{"key":"3632_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/children9071099","author":"ME Lyon","year":"2022","unstructured":"Lyon ME, Wiener L. Special issue psychosocial considerations for children and adolescents living with a rare disease. Children (Basel). 2022. https:\/\/doi.org\/10.3390\/children9071099.","journal-title":"Children (Basel)"},{"issue":"1","key":"3632_CR27","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.ymgme.2021.12.010","volume":"135","author":"PMJ Bergs","year":"2022","unstructured":"Bergs PMJ, Maas DM, Janssen MCH, et al. Feasible and clinical relevant outcome measures for adults with mitochondrial disease. Mol Genet Metab. 2022;135(1):102\u20138. https:\/\/doi.org\/10.1016\/j.ymgme.2021.12.010.","journal-title":"Mol Genet Metab"},{"issue":"4","key":"3632_CR28","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.pediatrneurol.2009.11.012","volume":"42","author":"KR Kim","year":"2010","unstructured":"Kim KR, Lee E, Namkoong K, et al. Caregiver\u2019s burden and quality of life in mitochondrial disease. Pediatr Neurol. 2010;42(4):271\u20136. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2009.11.012.","journal-title":"Pediatr Neurol"},{"issue":"1","key":"3632_CR29","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1136\/jmedgenet-2021-108006","volume":"60","author":"K Bjorkman","year":"2023","unstructured":"Bjorkman K, Vissing J, Ostergaard E, et al. Phenotypic spectrum and clinical course of single large-scale mitochondrial DNA deletion disease in the paediatric population: a multicentre study. J Med Genet. 2023;60(1):65\u201373. https:\/\/doi.org\/10.1136\/jmedgenet-2021-108006.","journal-title":"J Med Genet"},{"issue":"1","key":"3632_CR30","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1186\/s13023-022-02538-9","volume":"17","author":"A Yoshimi","year":"2022","unstructured":"Yoshimi A, Ishikawa K, Niemeyer C, et al. Pearson syndrome: a multisystem mitochondrial disease with bone marrow failure. Orphanet J Rare Dis. 2022;17(1):379. https:\/\/doi.org\/10.1186\/s13023-022-02538-9.","journal-title":"Orphanet J Rare Dis"},{"key":"3632_CR31","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.mito.2019.10.005","volume":"50","author":"NS Poulsen","year":"2020","unstructured":"Poulsen NS, Madsen KL, Hornsyld TM, et al. Growth and differentiation factor 15 as a biomarker for mitochondrial myopathy. Mitochondrion. 2020;50:35\u201341. https:\/\/doi.org\/10.1016\/j.mito.2019.10.005.","journal-title":"Mitochondrion"},{"issue":"2","key":"3632_CR32","doi-asserted-by":"publisher","first-page":"e0148709","DOI":"10.1371\/journal.pone.0148709","volume":"11","author":"R Montero","year":"2016","unstructured":"Montero R, Yubero D, Villarroya J, et al. GDF-15 is elevated in children with mitochondrial diseases and is induced by mitochondrial dysfunction. PLoS ONE. 2016;11(2):e0148709. https:\/\/doi.org\/10.1371\/journal.pone.0148709.","journal-title":"PLoS ONE"},{"issue":"4","key":"3632_CR33","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/crt2.41","volume":"6","author":"J Flickinger","year":"2021","unstructured":"Flickinger J, Fan J, Wellik A, et al. Development of a mitochondrial myopathy-composite assessment tool. JCSM Clin Rep. 2021;6(4):109\u201327.","journal-title":"JCSM Clin Rep"},{"issue":"2","key":"3632_CR34","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1002\/jimd.12307","volume":"44","author":"JM Lehtonen","year":"2021","unstructured":"Lehtonen JM, Auranen M, Darin N, et al. Diagnostic value of serum biomarkers FGF21 and GDF15 compared to muscle sample in mitochondrial disease. J Inherit Metab Dis. 2021;44(2):469\u201380. https:\/\/doi.org\/10.1002\/jimd.12307.","journal-title":"J Inherit Metab Dis"},{"issue":"6","key":"3632_CR35","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1097\/MNH.0b013e32834b8850","volume":"20","author":"LA Inker","year":"2011","unstructured":"Inker LA, Okparavero A. Cystatin C as a marker of glomerular filtration rate: prospects and limitations. Curr Opin Nephrol Hypertens. 2011;20(6):631\u20139. https:\/\/doi.org\/10.1097\/MNH.0b013e32834b8850.","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"1","key":"3632_CR36","doi-asserted-by":"publisher","first-page":"14","DOI":"10.2174\/1573399811666150701143112","volume":"12","author":"RT Ribeiro","year":"2016","unstructured":"Ribeiro RT, Macedo MP, Raposo JF. HbA1c, fructosamine, and glycated albumin in the detection of dysglycaemic conditions. Curr Diabetes Rev. 2016;12(1):14\u20139. https:\/\/doi.org\/10.2174\/1573399811666150701143112.","journal-title":"Curr Diabetes Rev"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03632-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-03632-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03632-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T14:11:37Z","timestamp":1757340697000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-025-03632-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,4]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3632"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-03632-4","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,4]]},"assertion":[{"value":"15 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research study was reviewed and approved by Castle Institutional Review Board (IRB) and accepted via Cooperative IRB Review by the Institutional Review Board at the Children\u2019s Hospital of Philadelphia. Research was conducted in conformance with 45 CFR 46 standards for the protection of human participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"ER declares she is the founder of The Champ Foundation and a parent of a child with Pearson syndrome. RDG declares that she receives consulting funds from Minovia Therapeutics and Nurture Genomics. LEM, MW, IGS, SN, KDS, MR, MP, and ACG have no competing interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"399"}}